The Fanconi Anemia Research Fund is a world leader in the search for a cure for Fanconi anemia. We fund basic and translational research that leads to better understanding of the disease and improves quality of life for individuals with FA. We are also a resource of information for physicians treating patients with FA.
Research Priorities: What kind of research do we fund? FARF promotes research that focuses on the rapid discovery and development of therapies or strategies that treat, control or cure FA.
Supported Research: We have supported 248 basic research and translational science grants since 1989. Read about our current and past research projects.
Become a FARF Researcher: Are you interested in studying FA? Learn how to join an esteemed community of FA researchers.
Meet Our Researchers: Some of the brightest minds in the world have worked on FA. Our 163 grantees come from a variety of science disciplines and they’re all working toward the same goal: to find better treatments and a cure for Fanconi anemia.
Research Materials: FARF can help provide you with biomedical samples for your research.
FA 101: get an overview of FA basic and clinical science.
Scientific Symposium: Every year we gather FA scientists, researchers and doctors from around the world to share results from their research and to collaborate with others in the field.
Clinical Care Guidelines: this handbook is for physicians who provide primary care for FA patients, as well as patients and families who wish to develop a more comprehensive medical understanding as they work to secure optimal treatment through consultation and appropriate referral. The guidelines are also available in Spanish, Italian, French, and Korean.
Relationship to Cancer: People with Fanconi anemia have a much greater risk of developing acute myeloid leukemia (AML) and other cancers than people without Fanconi anemia.
We believe that research is the answer to one day making Fanconi anemia a treatable condition so that those diagnosed with the disease can live long, healthy lives. After years dedicated to gene identification, improving bone marrow transplantation, and uncovering connections to breast and other cancers, FA scientists are now poised to create less toxic therapies and improve and extend lives. Read about our funded research.